Effect of experimental parameters on the in vitro release kinetics of transforming growth factor β1 from coral particles

被引:16
作者
Demers, CN
Tabrizian, M
Petit, A
Hamdy, RC
Yahia, L
机构
[1] Ecole Polytech, Dept Mech Engn, BBRG, Montreal, PQ H3C 3A7, Canada
[2] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Lady Davis Inst Med Res, Div Orthopaed Surg, Montreal, PQ H3T 1E2, Canada
[4] McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada
[5] McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3G 1A6, Canada
[6] McGill Univ, Dept Orthopaed, Montreal, PQ H3G 1A6, Canada
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH | 2002年 / 59卷 / 03期
关键词
coral particles; transforming growth factor beta 1; protein adsorption; growth factor delivery system; coral degradation;
D O I
10.1002/jbm.1256
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Coral bone graft substitutes have been supplemented in the past with growth factors to further enhance bone regeneration in defects. Little is known, however, on the dynamics of protein release from coral. Coral particles were studied for their ability to release transforming growth factor beta 1 (TGF-beta1) in vitro, under different adsorption conditions. Adsorption of TGF-beta1 (0.05 mug/mL) on coral particles (<80 <mu>m or 300-450 mum) after 24 h of incubation was high, regardless of conditions. TGF-beta1 release kinetics in an artificial bone fluid followed a specific profile: an initial 1-h protein burst, followed by a decreasing release during the next 24 h at which time the release increased again to reach a constant rate until the end of the 2-week study. The protein release rate appeared mainly to depend upon the diffusion of TGF-beta1. TGF-beta1 release from coral particles was enhanced in the presence of bovine serum albumin (BSA) compared to the release in the presence of gelatin, and was dependent on the pH of adsorption. The highest total TGF-beta1 release was obtained when adsorption occurred with BSA at pH 7.4 (82 +/-3%), while the lowest release was observed when adsorption was done in the presence of gelatin at pH 11 (38 +/-1%). TGF-beta1 release was also found to vary with particle size, higher release being obtained with the smaller particles. These results suggest that coral particles could be used as a delivery system for growth factors, and that the release rate may be modulated through modification of the adsorption conditions and coral particle size. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 59: 403-410,2002.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 45 条
[1]   Osteogenesis with coral is increased by BMP and BMC in a rat cranioplasty [J].
Arnaud, E ;
De Pollak, C ;
Meunier, A ;
Sedel, L ;
Damien, C ;
Petite, H .
BIOMATERIALS, 1999, 20 (20) :1909-1918
[2]  
Arnaud E, 1998, Ann Chir Plast Esthet, V43, P40
[3]   COMPARATIVE-STUDY OF THE OSTEOINDUCTIVE PROPERTIES OF BIOCERAMIC, CORAL AND PROCESSED BONE-GRAFT SUBSTITUTES [J].
BEGLEY, CT ;
DOHERTY, MJ ;
MOLLAN, RAB ;
WILSON, DJ .
BIOMATERIALS, 1995, 16 (15) :1181-1185
[4]   The use of an osteoinductive growth factor for lumbar spinal fusion .2. Study of dose, carrier, and species [J].
Boden, SD ;
Schimandle, JH ;
Hutton, WC .
SPINE, 1995, 20 (24) :2633-2644
[5]   ROLE OF ACTIVE AND LATENT TRANSFORMING GROWTH-FACTOR-BETA IN BONE-FORMATION [J].
BONEWALD, LF ;
DALLAS, SL .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 55 (03) :350-357
[6]   Transforming growth factor beta in fracture repair [J].
Bostrom, MPG ;
Asnis, P .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1998, (355) :S124-S131
[7]   MECHANICAL-PROPERTIES OF CORAL SKELETON - COMPRESSIVE STRENGTH AND ITS ADAPTIVE SIGNIFICANCE [J].
CHAMBERLAIN, JA .
PALEOBIOLOGY, 1978, 4 (04) :419-435
[8]  
Chinn J. A., 1995, BIOMEDICAL ENG HDB, P1597
[9]   IMMUNODETECTION AND QUANTITATION OF THE 2 FORMS OF TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA-1 AND TGF-BETA-2) SECRETED BY CELLS IN CULTURE [J].
DANIELPOUR, D ;
DART, LL ;
FLANDERS, KC ;
ROBERTS, AB ;
SPORN, MB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 138 (01) :79-86
[10]   Effects of TGF-β on the immune system:: implications for cancer immunotherapy [J].
de Visser, KE ;
Kast, WM .
LEUKEMIA, 1999, 13 (08) :1188-1199